Cargando…
Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach
OBJECTIVE: To develop and validate a responsive and feasible ultrasound inflammation score for rheumatoid arthritis (RA). METHODS: We used data from cohorts of early RA (development) and established RA starting/switching biologic therapy (validation). 4 tendons and 36 joints were examined by a grey...
Autores principales: | Aga, Anna-Birgitte, Berner Hammer, Hilde, Christoffer Olsen, Inge, Uhlig, Till, Kvien, Tore K, van der Heijde, Désirée, Fremstad, Hallvard, Madland, Tor Magne, Lexberg, Åse Stavland, Haukeland, Hilde, Rødevand, Erik, Høili, Christian, Stray, Hilde, Noraas, Anne Lindtner, Widding Hansen, Inger Johanne, Bakland, Gunnstein, Lillegraven, Siri, Lie, Elisabeth, Haavardsholm, Espen A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174791/ https://www.ncbi.nlm.nih.gov/pubmed/28074154 http://dx.doi.org/10.1136/rmdopen-2016-000325 |
Ejemplares similares
-
Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial
por: Haavardsholm, Espen A, et al.
Publicado: (2016) -
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
por: Lillegraven, Siri, et al.
Publicado: (2023) -
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
por: Nordberg, Lena Bugge, et al.
Publicado: (2018) -
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
por: Paulshus Sundlisæter, Nina, et al.
Publicado: (2022) -
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
por: Sundin, Ulf, et al.
Publicado: (2021)